Pioglitazone in addition to metformin improves erythrocyte deformability in patients with type 2 diabetes mellitus. Results from the PIOfix study

被引:0
|
作者
Forst, S. [1 ]
Loebig, M. [1 ]
Lehmann, U. [2 ]
Hohberg, C. [1 ]
Friedrich, C. [1 ]
Fuchs, W. [2 ]
Pfuetzner, A. [1 ]
Forst, T. [1 ]
机构
[1] Inst Clin Res & Dev, Mainz, Germany
[2] Takeda Pharma, Dept Med, Aachen, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1265
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Pioglitazone Compared with Metformin Increases Pericardial Fat Volume in Patients with Type 2 Diabetes Mellitus
    Jonker, J. T.
    Lamb, H. J.
    van der Meer, R. W.
    Rijzewijk, L. J.
    Menting, L. J.
    Diamant, M.
    Bax, J. J.
    de Roos, A.
    Romijn, J. A.
    Smit, J. W. A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (01): : 456 - 460
  • [22] A Differential Effect of Pioglitazone Versus Metformin on Fat Depots in Patients with Type 2 Diabetes Mellitus
    Jonker, Jacqueline T.
    Van der Meer, Rutger W.
    Rijzewijk, Luuk J.
    Menting, Lisa J.
    Diamant, Michaela
    De Roos, Albert
    Lamb, Hildo J.
    Smit, Johannes W. A.
    Romijn, Johannes A.
    DIABETES, 2009, 58 : A172 - A172
  • [23] The Addition of Sitagliptin to Metformin and Pioglitazone Therapy Enhances Glycemic Control in Patients with Type 2 Diabetes
    Fonseca, Vivian
    Staels, Bart
    Morgan, Jerry D., II
    Yue Shentu
    Golm, Gregory T.
    Johnson-Levonas, Amy O.
    Kaufman, Keith D.
    Goldstein, Barry J.
    Steinberg, Helmut
    Henry, Robert
    DIABETES, 2011, 60 : A308 - A308
  • [24] Dapagliflozin acutely improves kidney function in type 2 diabetes mellitus. The PRECARE study
    Lazzaroni, Elisa
    Lunati, Maria Elena
    Montefusco, Laura
    Pastore, Ida
    Chebat, Enrica
    Cimino, Vincenzo
    Morpurgo, Paola Silvia
    Muratori, Milena
    Plebani, Laura
    Bolla, Andrea
    Rossi, Antonio
    Vallone, Luciana
    Gandolfi, Alessandra
    Tinari, Camilla
    D'Addio, Francesca
    Ben Nasr, Moufida
    Loretelli, Cristian
    Scaranna, Cristiana
    Bellante, Rosalia
    Manfrini, Roberto
    Muratori, Fabrizio
    Franzetti, Ivano
    Orsi, Emanuela
    Gazzaruso, Carmine
    Ghelardi, Renata
    Desenzani, Paolo
    Genovese, Stefano
    Girelli, Angela
    Folli, Franco
    Berra, Cesare
    Fiorina, Paolo
    PHARMACOLOGICAL RESEARCH, 2022, 183
  • [25] Progressive impairment of erythrocyte deformability as indicator of microangiopathy in type 2 diabetes mellitus
    Shin, Sehyun
    Ku, Yun-Hee
    Ho, Jian-Xun
    Kim, Yu-Kyung
    Suh, Jang-Soo
    Singh, Megha
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2007, 36 (03) : 253 - 261
  • [26] Combination therapy with pioglitazone and metformin in patients with type 2 diabetes
    Egan, J
    Rubin, C
    Mathisen, A
    DIABETES, 1999, 48 : A117 - A117
  • [27] Effects of Metformin and Pioglitazone on Serum Pentosidine Levels in Type 2 Diabetes Mellitus
    Kanazawa, I.
    Yamamoto, M.
    Yamaguchi, T.
    Sugimoto, T.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2011, 119 (06) : 362 - 365
  • [28] Withdrawal of pioglitazone in patients with type 2 diabetes mellitus
    Iwase, M.
    Asano, T.
    Sasaki, N.
    Yoshizumi, H.
    Hiramatsu, S.
    Sakai, Y.
    Ogo, A.
    Iida, M.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (04) : 401 - 408
  • [29] Comparison of efficacy between Pioglitazone and metformin in treating type 2 diabetes mellitus
    Yu, YR
    Li, YB
    Fan, JY
    Wang, YG
    DIABETES, 2002, 51 : A480 - A480
  • [30] Periodontal status of patients with type 2 diabetes mellitus.
    Sugihara, K.
    Hayashi, J.
    Ohashi, T.
    Goto, S.
    Hasegawa, A.
    Shin, K.
    JOURNAL OF DENTAL RESEARCH, 2003, 82 : B287 - B287